Global e-prescribing market is estimated to be valued at US$ 1,655.06 million in 2022 and is expected to exhibit a CAGR of 18.5% during the forecast period (2022-2030).
Figure 1. Global E-Prescribing Market Market Share (%), by Product Type, 2022
Increasing launch of new technologies in service platform is expected to drive the growth of global e-prescribing market over the forecast period.
Increasing launch of new technologies in service platform is expected to drive the growth of global e-prescribing market over the forecast period. For instance, on March 15, 2022, FDB (First Databank, Inc.), the provider of drug knowledge that helps healthcare professionals make precise decisions, announced the launch of FDB Vela, a new, cloud-native electronic prescribing (ePrescribing) network that enables the seamless flow of critical medication prescription information, benefits verification, and clinical decision support between prescribers, payers, pharmacies, and other constituents. With the launch of FDB Vela, participants including electronic health record (EHR) developers and other technology partners, payers, pharmacy benefit managers (PBMs) and pharmacies have a new choice that provides accessibility to all types of participants, easy onboarding, and the ability to leverage advanced functionalities to streamline prescribing and fulfillment.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients